|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation of property, plant and equipment | |||||
| Amortization of acquisition-related intangible assets | |||||
| Change in deferred income taxes | |||||
| Stock-based compensation | |||||
| Loss on early extinguishment of debt | |||||
| Other net non-cash expenses | |||||
| Changes in assets and liabilities, excluding the effects of acquisitions: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Contract assets/liabilities | |||||
| Accounts payable | |||||
| Contributions to retirement plans | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Proceeds from cross-currency interest rate swap interest settlements | |||||
| Acquisitions, net of cash acquired | |||||
| Purchases of investments | |||||
| Proceeds from sales and maturities of investments | |||||
| Other investing activities, net | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Net proceeds from issuance of debt | |||||
| Repayment of debt | |||||
| Proceeds from issuance of commercial paper | |||||
| Repayments of commercial paper | |||||
| Purchases of company common stock | |||||
| Dividends paid | |||||
| Other financing activities, net | |||||
| Net cash provided by/(used in) financing activities | |||||
| Exchange rate effect on cash | |||||
| Increase/(decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
Loading...
